Why are U.S. girls getting meningococcal but not human papilloma virus vaccines? Comparison of factors associated with human papilloma virus and meningococcal vaccination among adolescent girls 2008 to 2012.

[1]  S. J. Henley,et al.  Human Papillomavirus-Associated Cancers - United States, 2008-2012. , 2016, MMWR. Morbidity and mortality weekly report.

[2]  William Fulp,et al.  Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study. , 2016, The Journal of infectious diseases.

[3]  Jack Clark,et al.  Missed Opportunities for HPV Vaccination in Adolescent Girls: A Qualitative Study , 2014, Pediatrics.

[4]  J. Macneil,et al.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2013 , 2014, MMWR. Morbidity and mortality weekly report.

[5]  Jenny Jeyarajah,et al.  Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States , 2014, MMWR. Morbidity and mortality weekly report.

[6]  S. Stokley,et al.  National and State Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2012 , 2013, MMWR. Morbidity and mortality weekly report.

[7]  E. Unger,et al.  Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. , 2013, The Journal of infectious diseases.

[8]  J. Schulkin,et al.  Challenges in cervical cancer prevention: a survey of U.S. obstetrician-gynecologists. , 2013, American journal of preventive medicine.

[9]  Bridgette M. Brawner,et al.  The Development of a Culturally Relevant, Theoretically Driven HPV Prevention Intervention for Urban Adolescent Females and Their Parents/Guardians , 2013, Health promotion practice.

[10]  J. Hadler,et al.  Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008–2011 , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[11]  J. Singer,et al.  Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial. , 2013, JAMA.

[12]  Nicola P Klein,et al.  Safety of quadrivalent human papillomavirus vaccine administered routinely to females. , 2012, Archives of pediatrics & adolescent medicine.

[13]  L. Dickinson,et al.  Effectiveness and Cost of Immunization Recall at School-Based Health Centers , 2012, Pediatrics.

[14]  L. Dickinson,et al.  Effectiveness and Net Cost of Reminder/Recall for Adolescent Immunizations , 2012, Pediatrics.

[15]  G. Flores,et al.  Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. , 2012, Vaccine.

[16]  M. Saraiya,et al.  Cancers that U.S. physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. , 2012, Journal of women's health.

[17]  H. Bergh,et al.  Primary healthcare nurses' experiences with motivational interviewing in health promotion practice. , 2011, Journal of clinical nursing.

[18]  T. Santibanez,et al.  Human Papillomavirus Vaccination Series Initiation and Completion, 2008–2009 , 2011, Pediatrics.

[19]  S. Strasser,et al.  Parent-Reported Reasons for Nonreceipt of Recommended Adolescent Vaccinations, National Immunization Survey—Teen, 2009 , 2011, Clinical pediatrics.

[20]  E. Roilides,et al.  Outcome of Urinary Tract Infections Caused by Extended Spectrum &bgr;-Lactamase-producing Enterobacteriaceae in Children , 2011, The Pediatric infectious disease journal.

[21]  J. Peterson,et al.  The Uptake of Human Papillomavirus (HPV) Vaccine Among Adolescent Females in the United States , 2011, The Journal of school nursing : the official publication of the National Association of School Nurses.

[22]  P. Liberatos,et al.  Pediatricians' Experience with and Response to Parental Vaccine Safety Concerns and Vaccine Refusals: A Survey of Connecticut Pediatricians , 2011, Public health reports.

[23]  L. Rodewald,et al.  Vaccination Coverage among U.S. Adolescents Aged 13–17 Years Eligible for the Vaccines for Children Program, 2009 , 2011, Public health reports.

[24]  R. Desmond,et al.  Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. , 2011, Journal of pediatric and adolescent gynecology.

[25]  P. Kerndt,et al.  Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. , 2011, Vaccine.

[26]  Peter A Ubel,et al.  Controversy undermines support for state mandates on the human papillomavirus vaccine. , 2010, Health affairs.

[27]  J. Hocking,et al.  Cancers attributable to human papillomavirus infection. , 2010, Sexual health.

[28]  Nicholas J. Horton.  Review of Multilevel and Longitudinal Modeling Using Stata, Second Edition, by Sophia Rabe-Hesketh and Anders Skrondal , 2008 .

[29]  G. Zimet,et al.  The HPV vaccine mandate controversy. , 2007, Journal of pediatric and adolescent gynecology.

[30]  G. Miller,et al.  Explaining Racial and Ethnic Differences in Children's Use of Stimulant Medications , 2007, Medical care.

[31]  J. Boom,et al.  Improvement in Provider Immunization Knowledge and Behaviors Following a Peer Education Intervention , 2007, Clinical pediatrics.

[32]  J. Seward,et al.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[33]  Elizabeth R Unger,et al.  Prevalence of HPV infection among females in the United States. , 2007, JAMA.

[34]  S. Franceschi,et al.  Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. , 2006, Vaccine.

[35]  Eva Alberman.  Prevention and Health Promotion , 2005, Journal of Public Health.

[36]  L. Barker,et al.  Children who have received no vaccines: who are they and where do they live? , 2004, Pediatrics.

[37]  Dylan M. Smith,et al.  Racial Disparities in Diabetes Care Processes, Outcomes, and Treatment Intensity , 2003, Medical care.

[38]  N. Kressin,et al.  Racial Differences in the Use of Invasive Cardiovascular Procedures: Review of the Literature and Prescription for Future Research , 2001, Annals of Internal Medicine.

[39]  R. Andersen,et al.  Understanding the context of healthcare utilization: assessing environmental and provider-related variables in the behavioral model of utilization. , 1998, Health services research.

[40]  T. Schacker,et al.  Clinical and Epidemiologic Features of Primary HIV Infection , 1996, Annals of Internal Medicine.

[41]  Nichols Sb.  Vaccines for children program. , 1994 .

[42]  J. Eisenberg,et al.  Changing physicians' practices. , 1993, Tobacco control.

[43]  E. Anderson.  Hudson et al. , 1977 .

[44]  P. Rosenberg,et al.  J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States , 2014 .

[45]  S. Omer,et al.  Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases , 2010 .